Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12287)
All Articles published online
|
Publishing Process of This Article
|
Jan 14, 2019 (publication date) through Jan 19, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gu JX, Zhang X, Miao RC, Xiang XH, Fu YN, Zhang JY, Liu C, Qu K. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. World J Gastroenterol 2019; 25(2): 220-232 [PMID: 30670911 DOI: 10.3748/wjg.v25.i2.220] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i2/220.htm |
| Number | Citing Articles |
| 1 |
Hao Zhang, Xuebing Chen, Jian Zhang, Xianwei Wang, Huijuan Chen, Lin Liu, Shanling Liu. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review). International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4909
|
| 2 |
Xiao-Xiao Li, Li-Juan Wang, Jie Hou, Hong-Yang Liu, Rui Wang, Chao Wang, Wen-Hai Xie, Jeroen T. Buijs. Identification of Long Noncoding RNAs as Predictors of Survival in Triple‐Negative Breast Cancer Based on Network Analysis. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/8970340
|
| 3 |
Jianhua Wu, Xueting Ren, Nan Wang, Ruina Zhou, Mengsha Chen, Yifan Cai, Shuai Lin, Hao Zhang, Xin Xie, Chengxue Dang, Shuqun Zhang, Zhangjian Zhou. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.779554
|
| 4 |
Jie Cao, Lili Wu, Xin Lei, Keqing Shi, Liang Shi. A signature of 13 autophagy‑related gene pairs predicts prognosis in hepatocellular carcinoma. Bioengineered 2021; 12(1): 697 doi: 10.1080/21655979.2021.1880084
|
| 5 |
Xinxin Zhang, Jia Yu, Juan Hu, Fang Tan, Juan Zhou, Xiaoyan Yang, Zhizhong Xie, Huifang Tang, Sen Dong, Xiaoyong Lei. 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2021; 24(5): 656 doi: 10.2174/1386207323666200914095616
|
| 6 |
Yaqiu Wu, Ling Liu, Zhili Li, Tian Zhang, Qi Wang, Meixiong Cheng. A Risk Model Based on Ferroptosis‐Related Genes OSMR, G0S2, IGFBP6, IGHG2, and FMOD Predicts Prognosis in Glioblastoma Multiforme. CNS Neuroscience & Therapeutics 2025; 31(1) doi: 10.1111/cns.70161
|
| 7 |
Huan Ding, Huan Hu, Feifei Tian, Huaping Liang. A dual immune signature of CD8+ T cells and MMP9 improves the survival of patients with hepatocellular carcinoma. Bioscience Reports 2021; 41(3) doi: 10.1042/BSR20204219
|
| 8 |
Zhaoxiong Hu, Linhong Li, Peng Cheng, Qin Liu, Xuan Zheng, Feng Peng, Qinghong Zhang. lncRNA MSC‐AS1 activates Wnt/β‐catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR‐3924/WNT5A. Journal of Cellular Biochemistry 2020; 121(10): 4085 doi: 10.1002/jcb.29594
|
| 9 |
Muqi Li, Minni Liang, Tian Lan, Xiwen Wu, Wenxuan Xie, Tielong Wang, Zhitao Chen, Shunli Shen, Baogang Peng. Four Immune-Related Long Non-coding RNAs for Prognosis Prediction in Patients With Hepatocellular Carcinoma. Frontiers in Molecular Biosciences 2020; 7 doi: 10.3389/fmolb.2020.566491
|
| 10 |
Cong Cao, Qiuhong Zhong, Liuxue Lu, Bin Huang, Jun Li, Lianxin Meng, Hua Wei. Long noncoding RNA MSC‐AS1 promotes hepatocellular carcinoma oncogenesis via inducing the expression of phosphoglycerate kinase 1. Cancer Medicine 2020; 9(14): 5174 doi: 10.1002/cam4.3080
|
| 11 |
Benyuan Deng, Min Yang, Ming Wang, Zhongwu Liu. Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma. Medicine 2020; 99(21): e20422 doi: 10.1097/MD.0000000000020422
|
| 12 |
Yi-tian Chen, Dan Xiang, Xiao-yue Zhao, Xiao-yuan Chu. Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m6A methylation promotes disease progression and sorafenib resistance. Human Cell 2021; 34(6): 1800 doi: 10.1007/s13577-021-00587-z
|
| 13 |
Sung Bae Park, Ki-Tae Hwang, Chun Kee Chung, Deodutta Roy, Changwon Yoo. Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer. Clinical & Experimental Metastasis 2020; 37(6): 657 doi: 10.1007/s10585-020-10060-0
|
| 14 |
Yuan‐Ming Wu, Yan Guo, Hui Yu, Tao Guo. RNA editing affects cis‐regulatory elements and predicts adverse cancer survival. Cancer Medicine 2021; 10(17): 6114 doi: 10.1002/cam4.4146
|
| 15 |
Chong Li, Shiyu Feng, Ling Chen. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Molecular and Cellular Biochemistry 2021; 476(2): 699 doi: 10.1007/s11010-020-03937-x
|
| 16 |
Tianmei Fu, Boxuan Zhou, Yingliang Li, Wei Liu, Yuankang Xie, Zhaohong Mo, Fang Yin, Yu Wang, Kang Fang, Yangyang Fang, Ziqing Xiong, Kuai Yu, Aiping Le. Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma. International Journal of Nanomedicine 2024; : 13183 doi: 10.2147/IJN.S498065
|
| 17 |
Ziming He, Di Tang. Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1230164
|
| 18 |
Soudeh Ghafouri-Fard, Mahdi Gholipour, Bashdar Mahmud Hussen, Mohammad Taheri. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.649107
|
| 19 |
Xinyu Li, Yong Zhou, Yongshuang Li, Liang Yang, Yingbo Ma, Xueqiang Peng, Shuo Yang, Jingang Liu, Hangyu Li. Autophagy: A novel mechanism of chemoresistance in cancers. Biomedicine & Pharmacotherapy 2019; 119: 109415 doi: 10.1016/j.biopha.2019.109415
|
| 20 |
Jun Lu, Ruichao Li, Minghao Fang, Shun Ke, Min Tang. Hub Genes and Long Noncoding RNAs That Regulates It Associated with the Prognosis of Esophageal Squamous Cell Carcinoma Based on Bioinformatics Analysis. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/6027058
|
| 21 |
Lin Wang, Hui Shi, Jia Wei, Wen-Xiu Chen, Yue-Xinzi Jin, Chun-Rong Gu, Yuan Mu, Jian Xu, Shi-Yang Pan. SP70 is a novel biomarker of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1149397
|
| 22 |
Qiong Zhang, Gang Ning, Hongye Jiang, Yanlin Huang, Jinsong Piao, Zhen Chen, Xiaojun Tan, Jiangyu Zhang, Genglong Liu, Stamatios E. Theocharis. 15-lncRNA-Based Classifier-Clinicopathologic Nomogram Improves the Prediction of Recurrence in Patients with Hepatocellular Carcinoma. Disease Markers 2020; 2020: 1 doi: 10.1155/2020/9180732
|
| 23 |
Juan Pablo Unfried, Paloma Sangro, Laura Prats-Mari, Bruno Sangro, Puri Fortes. The Landscape of lncRNAs in Hepatocellular Carcinoma: A Translational Perspective. Cancers 2021; 13(11): 2651 doi: 10.3390/cancers13112651
|
| 24 |
Yang Zhang, Yan Yang, Yi Zhang, Zhisu Liu. lncRNA ST8SIA6‑AS1 facilitates proliferation and invasion in liver cancer by regulating miR‑142‑3p. Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10783
|
| 25 |
Wenhua Wang, Lingchen Wang, Xinsheng Xie, Yehong Yan, Yue Li, Quqin Lu. A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07692-6
|
| 26 |
Aroosha Raja, Farhan Haq. Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications. Journal of Cancer Research and Clinical Oncology 2022; 148(1): 15 doi: 10.1007/s00432-021-03826-w
|
| 27 |
Jianguo Qi, Zhengrui Wang, Zhensheng Zhao, Lijun Liu. EIF3J-AS1 promotes glioma cell growth via up-regulating ANXA11 through sponging miR-1343-3p. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01487-2
|
| 28 |
Qinran Zhang, Yuhong Xu, Shiyang Kang, Junquan Chen, Zhihao Yao, Haitao Wang, Qinian Wu, Qi Zhao, Qihua Zhang, Rui‐hua Xu, Xiufen Zou, Huiyan Luo. A novel computational framework for integrating multidimensional data to enhance accuracy in predicting the prognosis of colorectal cancer. MedComm – Future Medicine 2022; 1(2) doi: 10.1002/mef2.27
|
| 29 |
Yi Fu, Anfeng Si, Xindong Wei, Xinjie Lin, Yujie Ma, Huimin Qiu, Zhinan Guo, Yong Pan, Yiru Zhang, Xiaoni Kong, Shibo Li, Yanjun Shi, Hailong Wu. Combining a machine-learning derived 4-lncRNA signature with AFP and TNM stages in predicting early recurrence of hepatocellular carcinoma. BMC Genomics 2023; 24(1) doi: 10.1186/s12864-023-09194-8
|
| 30 |
Guo Long, Lihua Zhao, Biao Tang, Ledu Zhou, Xingyu Mi, Wenxin Su, Liang Xiao. A robust panel based on genomic methylation sites for recurrence-free survival in early hepatocellular carcinoma. Heliyon 2023; 9(9): e19434 doi: 10.1016/j.heliyon.2023.e19434
|
| 31 |
Wang Li, Qi-Feng Chen, Tao Huang, Peihong Wu, Lujun Shen, Zi-Lin Huang. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00780
|
| 32 |
Jie Cui, Qingquan Wen, Xiaojun Tan, Jinsong Piao, Qiong Zhang, Qian Wang, Lizhen He, Yan Wang, Zhen Chen, Genglong Liu. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53811-0
|
| 33 |
Yushan Huang, Longchang Jiang, Yang Liu, Lixian Liu, Junling Wang, Lei Shi. Long non‐coding RNAs in virus‐related cancers. Reviews in Medical Virology 2022; 32(6) doi: 10.1002/rmv.2364
|
| 34 |
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma. PeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
|
| 35 |
Setayesh Baradaran-Bagherian, Mahdieh Mehrab Mohseni, Roya Sharifi, Roya Amirinejad, Zeinab Shirvani-Farsani. The oxidative stress-associated long non-coding RNAs in pancreatic cancer. Advances in Medical Sciences 2024; 69(2): 231 doi: 10.1016/j.advms.2024.04.006
|
| 36 |
Wenxi Wang, Ruoyu Zhou, Yuwei Wu, Yicong Liu, Wenjia Su, Wei Xiong, Zhaoyang Zeng. PVT1 Promotes Cancer Progression via MicroRNAs. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00609
|
| 37 |
Weige Zhou, Shijing Zhang, Hui-biao Li, Zheyou Cai, Shuting Tang, Li-xia Chen, Jian-ying Lang, Zheng Chen, Xin-lin Chen, Bilal Alatas. Development of Prognostic Indicator Based on Autophagy‐Related lncRNA Analysis in Colon Adenocarcinoma. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/9807918
|
| 38 |
Anmei Wang, Junhua Lei. Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis. Medicine 2021; 100(5): e23749 doi: 10.1097/MD.0000000000023749
|
| 39 |
Cui Wang, Feng Zhao, Yunliang He, Yajun E, Shanfeng Li. Long non-coding RNA RMST serves as a diagnostic biomarker in patients with carotid artery stenosis and predicts the occurrence of cerebral ischemic event: A retrospective study. Vascular 2023; 31(5): 908 doi: 10.1177/17085381221100095
|
| 40 |
Qianyu Tang, Min Zeng, Linxi Chen, Nian Fu. Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.871100
|
| 41 |
Aditi Kulkarni, Sharan Gayathrinathan, Soumya Nair, Anamika Basu, Taslim A. Al-Hilal, Sourav Roy. Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities. Cells 2022; 11(15): 2448 doi: 10.3390/cells11152448
|
| 42 |
Weihao Kong, Xingyu Wang, Xiaomin Zuo, Zhongxiang Mao, Ya Cheng, Wei Chen. Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.01037
|
| 43 |
Willian A. da Silveira, Ludivine Renaud, Edward S. Hazard, Gary Hardiman. miRNA and lncRNA Expression Networks Modulate Cell Cycle and DNA Repair Inhibition in Senescent Prostate Cells. Genes 2022; 13(2): 208 doi: 10.3390/genes13020208
|
| 44 |
Zhijie Xu, Bi Peng, Qiuju Liang, Xi Chen, Yuan Cai, Shuangshuang Zeng, Kewa Gao, Xiang Wang, Qiaoli Yi, Zhicheng Gong, Yuanliang Yan. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.719175
|
| 45 |
Bo Song, Lijun Tian, Fan Zhang, Zheyu Lin, Boshen Gong, Tingting Liu, Weiping Teng. A novel signature to predict thyroid cancer prognosis and immune landscape using immune-related LncRNA pairs. BMC Medical Genomics 2022; 15(1) doi: 10.1186/s12920-022-01332-7
|
| 46 |
Ju A Son, Hye Ri Ahn, Donglim You, Geum Ok Baek, Moon Gyong Yoon, Jung Hwan Yoon, Hyo Jung Cho, Soon Sun Kim, Suk Woo Nam, Jung Woo Eun, Jae Youn Cheong. Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. Cancers 2022; 14(4): 865 doi: 10.3390/cancers14040865
|
| 47 |
Xue Yang, Bowen Yao, Yongshen Niu, Tianxiang Chen, Huanye Mo, Liang Wang, Cheng Guo, Demao Yao. Hypoxia-induced lncRNA EIF3J-AS1 accelerates hepatocellular carcinoma progression via targeting miR-122–5p/CTNND2 axis. Biochemical and Biophysical Research Communications 2019; 518(2): 239 doi: 10.1016/j.bbrc.2019.08.039
|
| 48 |
Sajad Najafi, Seyyed Hossein Khatami, Marjan Khorsand, Zeinab Jamali, Zahra Shabaninejad, Mostafa Moazamfard, Jamal Majidpoor, Seyed Mohsen Aghaei Zarch, Ahmad Movahedpour. Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis. Experimental Cell Research 2022; 418(2): 113294 doi: 10.1016/j.yexcr.2022.113294
|
| 49 |
Hongjun Xie, Muqi Shi, Yifei Liu, Changhong Cheng, Lining Song, Zihan Ding, Huanzhi Jin, Xiaohong Cui, Yan Wang, Dengfu Yao, Peng Wang, Min Yao, Haijian Zhang. Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.914977
|
| 50 |
Yudong Cao, Hecheng Zhu, Jun Tan, Wen Yin, Quanwei Zhou, Zhaoqi Xin, Zhaoping Wu, Zhipeng Jiang, Youwei Guo, Yirui Kuang, Can Li, Ming Zhao, Xingjun Jiang, Jiahui Peng, Caiping Ren. Development of an Immune-Related LncRNA Prognostic Signature for Glioma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.678436
|
| 51 |
Guolin Wu, Zhenfeng Deng, Zongrui Jin, Jilong Wang, Banghao Xu, Jingjing Zeng, Minhao Peng, Zhang Wen, Ya Guo, Yujiang Fang. Identification of Prognostic Immune‐Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/1346045
|
| 52 |
Bo-Tao Duan, Xue-Kai Zhao, Yang-Yang Cui, De-Zheng Liu, Lin Wang, Lei Zhou, Xing-Yuan Zhang. Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma. World Journal of Gastrointestinal Surgery 2024; 16(3): 842-859 doi: 10.4240/wjgs.v16.i3.842
|
| 53 |
Changhong He, Xia Wang, Meichun Du, Yanjun Dong, Alamgeer Yuchi. LncRNA MSC-AS1 Promotes Colorectal Cancer Progression by Regulating miR-325/TRIM14 Axis. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9954214
|
| 54 |
Jinfeng Zhu, Qian Huang, Sicheng Liu, Xingyu Peng, Ju Xue, Tangbin Feng, Wulang Huang, Zhimeng Chen, Kuiyuan Lai, Yufei Ji, Miaomiao Wang, Rongfa Yuan. Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.856186
|
| 55 |
Berta Luzón-Toro, Leticia Villalba-Benito, Raquel María Fernández, Ana Torroglosa, Guillermo Antiñolo, Salud Borrego. RMRP, RMST, FTX and IPW: novel potential long non-coding RNAs in medullary thyroid cancer. Orphanet Journal of Rare Diseases 2021; 16(1) doi: 10.1186/s13023-020-01665-5
|
| 56 |
Hanyi Zeng, Chengdong Liu, Xiaohan Zhou, Li Liu. A New Prognostic Strategy Based on four DNA Repair-Associated
lncRNAs for Hepatocellular Carcinoma. Combinatorial Chemistry & High Throughput Screening 2022; 25(5): 906 doi: 10.2174/1386207324666210302091432
|
| 57 |
Arian Mansur, Andrea Vrionis, Jonathan P. Charles, Kayesha Hancel, John C. Panagides, Farzad Moloudi, Shams Iqbal, Dania Daye. The Role of Artificial Intelligence in the Detection and Implementation of Biomarkers for Hepatocellular Carcinoma: Outlook and Opportunities. Cancers 2023; 15(11): 2928 doi: 10.3390/cancers15112928
|
| 58 |
Hongchen Qu, Minghuan Mao, Kai Wang, Zhongyi Mu, Bin Hu. Knockdown of ADAM8 inhibits the proliferation, migration, invasion, and tumorigenesis of renal clear cell carcinoma cells to enhance the immunotherapy efficacy. Translational Research 2024; 266: 32 doi: 10.1016/j.trsl.2023.11.003
|
| 59 |
Hugo Pinto-Marques, Joana Cardoso, Sílvia Silva, João L. Neto, Maria Gonçalves-Reis, Daniela Proença, Marta Mesquita, André Manso, Sara Carapeta, Mafalda Sobral, Antonio Figueiredo, Clara Rodrigues, Adelaide Milheiro, Ana Carvalho, Rui Perdigoto, Eduardo Barroso, José B. Pereira-Leal. A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. Annals of Surgery 2022; 276(5): 868 doi: 10.1097/SLA.0000000000005637
|
| 60 |
Ruoyang Du, Qing Xiao, Jianfeng Huang, Wubing Feng, Xiangqi Zheng, Tong Yi. A Seven-Autophagy-Related Long Non-Coding RNA Signature Can Accurately Predict the Prognosis of Patients with Renal Cell Carcinoma. International Journal of General Medicine 2022; : 8143 doi: 10.2147/IJGM.S381027
|
| 61 |
Xiang-Xu Wang, Li-Hong Wu, Liping Ai, Wei Pan, Jing-Yi Ren, Qiong Zhang, Hong-Mei Zhang. Construction of an HCC recurrence model based on the investigation of immune-related lncRNAs and related mechanisms. Molecular Therapy - Nucleic Acids 2021; 26: 1387 doi: 10.1016/j.omtn.2021.11.006
|
| 62 |
Haitao Jiang, Lianhe Zhao, Yunjie Chen, Liang Sun. A four‐long noncoding RNA signature predicts survival of hepatocellular carcinoma patients. Journal of Clinical Laboratory Analysis 2020; 34(9) doi: 10.1002/jcla.23377
|
| 63 |
Wenbiao Chen, Minglin Ou, Donge Tang, Yong Dai, Weibo Du. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma. Journal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/5494858
|
| 64 |
Nazia Samudh, Creanne Shrilall, Patrick Arbuthnot, Kristie Bloom, Abdullah Ely. Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.834650
|
| 65 |
Fan Jiang, Zheng Zhan, Yanbo Yang, Guangjie Liu, Song Liu, Jingyu Gu, Zhouqing Chen, Zhong Wang, Gang Chen, Bin Liu. Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/5681206
|
| 66 |
Adriana Fodor, Adriana Rusu, Gabriela Roman, Ramona Suharoschi, Romana Vulturar, Adela Sitar-Tăut, Angela Cozma. Medical Epigenetics. 2021; : 143 doi: 10.1016/B978-0-12-823928-5.00021-9
|
| 67 |
Hongchao Yao, Like Yang, Linli Tian, Yan Guo, Yushan Li. LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2). Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01202-1
|
| 68 |
Jinfeng Zhang, Xiaodong Ling, Chengyuan Fang, Jianqun Ma. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma. Cellular & Molecular Biology Letters 2022; 27(1) doi: 10.1186/s11658-022-00331-x
|
| 69 |
Lizhong Zeng, Wei Wang, Yang Chen, Xin Lv, Jingyan Yuan, Ruiying Sun, Shuanying Yang. A five‑long non‑coding RNA signature with the ability to predict overall survival of patients with lung adenocarcinoma . Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.8138
|
| 70 |
Zi-Lin Huang, Wang Li, Qi-Feng Chen, Pei-Hong Wu, Lu-Jun Shen. Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targets. World Journal of Gastrointestinal Oncology 2019; 11(11): 983-997 doi: 10.4251/wjgo.v11.i11.983
|
| 71 |
Zeyu Wang, Ningning Zhang, Jiayu Lv, Cuihua Ma, Jie Gu, Yawei Du, Yibo Qiu, Zhiguang Zhang, Man Li, Yong Jiang, Jianqiu Zhao, Huiqin Du, Zhiwei Zhang, Wei Lu, Yan Zhang, Luca Miele. A Five‐Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4037639
|
| 72 |
Sepideh Dashti, Mohammad Taheri, Soudeh Ghafouri-Fard. An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-76024-2
|
| 73 |
Hong Cheng, Mei Sun, Zhao-Lu Wang, Qian Wu, Juan Yao, Guang Ren, Xiu-Lan Sun. LncRNA RMST-mediated miR-107 transcription promotes OGD-induced neuronal apoptosis via interacting with hnRNPK. Neurochemistry International 2020; 133: 104644 doi: 10.1016/j.neuint.2019.104644
|
| 74 |
Haiping Zhao, Shiwei Zhang, Shijie Shao, Haixing Fang. Identification of a Prognostic 3-Gene Risk Prediction Model for Thyroid Cancer. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00510
|
| 75 |
Dingsheng Liu, Hong Zhang, Jinchun Cong, Mingming Cui, Mingxing Ma, Fangyuan Zhang, Huayi Sun, Chunsheng Chen. H3K27 acetylation‐induced lncRNA EIF3J‐AS1 improved proliferation and impeded apoptosis of colorectal cancer through miR‐3163/YAP1 axis. Journal of Cellular Biochemistry 2020; 121(2): 1923 doi: 10.1002/jcb.29427
|
| 76 |
Yaqiong Zhang, Liming Zhang, Youwen Xu, Xiaoyu Wu, Yong Zhou, Jinggang Mo. Immune‐related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. Journal of Cellular Physiology 2020; 235(12): 9304 doi: 10.1002/jcp.29730
|
| 77 |
Qianhui Xu, Yuxin Wang, Wen Huang. Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma. International Immunopharmacology 2021; 92: 107333 doi: 10.1016/j.intimp.2020.107333
|
| 78 |
Jun Zuo, Hongquan Ye, Jing Tang, Jianqun Lu, Qi Wan, Sentaro Kusuhara. Development of a 3-MicroRNA Signature and Nomogram for Predicting the Survival of Patients with Uveal Melanoma Based on TCGA and GEO Databases. Journal of Ophthalmology 2022; 2022: 1 doi: 10.1155/2022/9724160
|
| 79 |
Juan P. Unfried, P. Fortes. LncRNAs in HCV Infection and HCV-Related Liver Disease. International Journal of Molecular Sciences 2020; 21(6): 2255 doi: 10.3390/ijms21062255
|
| 80 |
Duguang Li, Shengxi Jin, Peng Chen, Yiyin Zhang, Yirun Li, Cheng Zhong, Xiaoxiao Fan, Hui Lin. Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.991604
|
| 81 |
Zhao-Shan Fang, Zhi Zhang, Zhi-Jie Liang, Zhong-Rong Long, Yi Xiao, Zhi-Yin Liang, Xing Sun, Hong-Mian Li, Hai Huang. Liquid–Liquid Phase Separation-Related Genes Associated with Tumor Grade and Prognosis in Hepatocellular Carcinoma: A Bioinformatic Study. International Journal of General Medicine 2021; : 9671 doi: 10.2147/IJGM.S342602
|
| 82 |
Ze-Kun Liu, Ke-Fei Wu, Ren-Yu Zhang, Ling-Min Kong, Run-Ze Shang, Jian-Jun Lv, Can Li, Meng Lu, Yu-Le Yong, Cong Zhang, Nai-Shan Zheng, Yan-Hong Li, Zhi-Nan Chen, Huijie Bian, Ding Wei. Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.794034
|
| 83 |
Nuo-Qing Weng, Jun Chi, Jing Wen, Shi-Juan Mai, Mei-Yin Zhang, Long Huang, Ji Liu, Xian-Zi Yang, Guo-Liang Xu, Jian-Hua Fu, Hui-Yun Wang. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02224-z
|
| 84 |
Yuhang Liu, Bingxin Liu, Guoying Jin, Jia Zhang, Xue Wang, Yuyang Feng, Zehua Bian, Bojian Fei, Yuan Yin, Zhaohui Huang. An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01269
|
| 85 |
Liangliang Qing, Peng Gu, Mingsheng Liu, Jihong Shen, Xiaodong Liu, Runyun Guang, Kunbin Ke, Zhuo Huang, Wenhui Lee, Hui Zhao. <p>Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer</p>. OncoTargets and Therapy 2020; : 12521 doi: 10.2147/OTT.S284167
|
| 86 |
Li Sun, Juan Li, Xiaomeng Li, Xuemei Yang, Shujun Zhang, Xue Wang, Nan Wang, Kanghong Xu, Xinquan Jiang, Yi Zhang. A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.676464
|
| 87 |
Shuyuan Li, Shuo Chen, Boxue Wang, Lin Zhang, Yinan Su, Xipeng Zhang. A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00056
|